Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21
GLP-1 medications require refrigeration for storage
Weight loss results vary significantly by specific medication and dose: Semaglutide 2.4 mg (Wegovy): Clinical trials (STEP program) showed average weight reductions of 1517% at 68 weeks Tirzepatide (Zepbound): SURMOUNT trials demonstrated weight reductions of 1522% at 72 weeks, with results varying between populations with and without diabetes Liraglutide 3 mg (Saxenda): Typically produces 510% weight loss over 56 weeks The rate of weight loss is not linear
Intended strictly for professional research environments
Higher work capacity : If you can get through the same workout faster or with less fatigue, your muscle endurance and strength are improving
US$ 20.35
US$ 29.57
US$ 21.55
